The G-CSF/G-CSFR signalling axis has been implicated in stimulating neoangiogenesis, tumour cell proliferation, enhanced migratory and metastatic potential, and expansion of the cancer stem cell pool in preclinical models of several solid organ malignancies [51]. This evidence concerns the gene CSF3R and cancer.